FDA green lights AstraZeneca's asthma drug Fasenra for self-administration

FDA green lights AstraZeneca's asthma drug Fasenra for self-administration
Reuters: Health
British drugmaker AstraZeneca said on Friday that the U.S. Food and Drug Administration (FDA) has approved self-administration of its asthma treatment Fasenra which uses a pre-filled, single-use auto-injector pen.